Drugmaker pays 23andMe $20 million for access to user DNA informationDrugmaker pays 23andMe $20 million for access to user DNA information
Drugmaker pays 23andMe $20 million for access to user DNA informationGSK Plc and 23andMe are expanding their partnership to give the drugmaking company access to the genetic company's database.